(Press-News.org) Each day, hundreds of billions of cells in our body cycle through a period of growth and division. Yet in that time, only about 30 minutes is spent on the critical orchestration of mitosis, when chromosomes are carefully segregated from one parent cell to the next generation of two daughter cells.
It’s during this crucial period of cell division that things can go haywire. Chromosomes can be misdirected, leading to damaged and diseased cells that progress to different types of cancer. University of California San Diego scientists reporting in the journal Science have found a key mechanism that keeps track of mitosis timing and takes note when the process takes too long. Researchers with the labs of Professors Arshad Desai and Karen Oegema in the School of Biological Sciences and School of Medicine have, for the first time, described the details of the mitosis “stopwatch” and the ways that suspicious cells are detected and stopped from further proliferating.
“This work shows that cells carefully monitor the time taken to execute mitosis and use that as a filter to eliminate potentially problematic cells,” said Desai, a faculty member in the Department of Cell and Developmental Biology. “If a cell takes longer than normal to complete mitosis, then daughter cells will know that their mother struggled to execute mitosis and they’ll stop dividing as a safety measure.”
The researchers discovered that the stopwatch is made up of a biochemical pathway that continually surveils the amount of time spent in mitosis. The pathway features a “memory” function that sums up mitosis delays from one generation to the next. Underlying the pathway is a complex of three proteins, including p53, encoded by the most commonly mutated gene in human cancers. Through a series of experiments, the researchers followed the pathway from parent to daughter and granddaughter cells over a 48-hour period. They found that the pathway works as a quality control mechanism that “remembers” mitotic time. Even cell divisions that are sequentially delayed by as little as 20 minutes are labeled as risky, they found.
The researchers believe the crucial 30 minutes of mitotic time could be evolution’s solution to quickly getting through a vital but potentially dangerous part of life when cells are vulnerable. Cancers, in Oegema’s view, are like an alien in our bodies that we are constantly fighting off using surveillance mechanisms like the stopwatch. Importantly, the researchers demonstrated that the stopwatch mechanism is switched “off” by many types of cancers, effectively allowing them to tolerate aberrant genomes that undergo longer and problematic mitoses.
“Our research suggests that measuring mitosis time is a mechanism that was developed as a way to protect us,” said Oegema, also a Cell and Developmental Biology Department professor. “Essentially, it’s another tumor-suppression function tied to p53’s job to protect against problematic cells.”
Looking ahead, the researchers noted in their Science study that their discovery could be used in future treatment strategies for cancer patients.
“Stopwatch status may influence the efficacy of therapeutic agents currently in use or being developed to target mitotic processes,” they note in the report, “and could serve as a potential biomarker for their use in cancer treatment.”
The coauthors of the paper are: Franz Meitinger, Hazrat Belal, Robert Davis, Mallory Martinez, Andrew Shiau, Karen Oegema and Arshad Desai.
END
Cell division quality control ‘stopwatch’ uncovered
Mechanism keeps track of the time cells take to split, sounding the alarm on cells that may turn cancerous
2024-03-28
ELSE PRESS RELEASES FROM THIS DATE:
Vaccine protects cattle from bovine tuberculosis, may eliminate disease
2024-03-28
UNIVERSITY PARK, Pa. — Bovine tuberculosis (TB) is a livestock disease that results in large economic losses to animal agriculture worldwide. The disease can also transmit to humans and cause severe illness and death. Researchers from Penn State, Addis Ababa University and the University of Cambridge have now demonstrated that a vaccine for TB currently used in humans significantly reduces infectiousness of vaccinated livestock, improving prospects for elimination and control. The study published today (March 28) in the journal Science.
The spillover ...
Andrew Siemion to receive the SETI Institute’s 2024 Drake Award
2024-03-28
March 28, 2024, Mountain View, CA -- The SETI Institute is pleased to announce that Dr. Andrew Siemion will be honored with the prestigious 2024 Drake Award for his exceptional and pioneering contributions to SETI and radio astronomy and his leadership in the field. Siemion's distinguished career includes his role as the Bernard M. Oliver Chair for SETI at the SETI Institute, Principal Investigator for the Breakthrough Listen Initiative at the University of Oxford, along with holding an Honorary Professorship ...
New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells
2024-03-28
Researchers at Karolinska Institutet, in collaboration with JLP Health and others, have identified how the tick-borne Crimean-Congo haemorrhagic fever virus enters our cells. The results are published in Nature Microbiology and are an important step in the development of drugs against the deadly disease.
Crimean-Congo haemorrhagic fever virus (CCHF virus) is spread through tick bites and can cause haemorrhagic fever. The disease is serious and has a mortality rate of up to 40 per cent depending on the health status of the person infected. Common symptoms ...
Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma
2024-03-28
In a recent multi-center study published in the Journal of the National Cancer Institute, researchers examined the effects of neoadjuvant chemotherapy (NAC) on patients suffering from locally advanced penile squamous cell carcinoma (PSCC). Dr. Kyle Rose, urologic oncologist at Ochsner MD Anderson Cancer Center, was the lead author for the publication.
The research included a cohort of 209 patients undergoing NAC, targeting locally advanced and clinically node positive PSCC. The patient group showed a diverse range of disease severity, with a distribution including 7% with stage II, 48% with stage III, and 45% with stage IV PSCC, ...
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes
2024-03-28
(MEMPHIS, Tenn. – March 28, 2024) Resistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Children’s Research Hospital scientists demonstrated that in bilateral Wilms tumor (cancer in both kidneys) chemotherapy resistance can point toward a more favorable histology and an ultimatelygood outcome. The study revealed that tumors that do not respond to neoadjuvant, or tumor-shrinking, chemotherapy are predominantly ...
Doctors received approximately $12.1 billion from drug and device makers between 2013-2022
2024-03-28
HERSHEY, Pa. — Despite evidence that financial conflicts of interest may influence medical practice and research and may erode patient trust in medical professionals, these relationships remain pervasive. According to a new analysis of the Open Payments platform, a database that tracks payments between physicians and industry, a team led by a Penn State researcher found that doctors received approximately $12.1 billion from drug and device makers between 2013 and 2022.
Their findings published today (March 28) in JAMA. It’s one of the first studies to look at industry payments longitudinally and by specialty.
“Overall, ...
Discovery suggests new strategy against follicular lymphoma
2024-03-28
A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients.
The study, published March 7 in Cancer Cell, showed that while mutations affecting a gene-regulating complex called BAF can put the cancer on a dangerous trajectory, they also make follicular lymphoma highly susceptible to experimental BAF-inhibitor drugs.
“These encouraging findings could address critical and urgent challenges with this disease and have prompted us to begin planning clinical trials ...
Making the future too bright: how wishful thinking can point us in the wrong direction
2024-03-28
Everyone indulges in wishful thinking now and again. But when is that most likely to happen and when could it actually be harmful? A new study, led by the University of Amsterdam (UvA), demonstrates unequivocally that the greater the insecurity and anxiety of a situation, the more likely people are to become overly optimistic – even to the point where it can prevent us from taking essential action. The study's results have now been published in the journal American Economic Review.
‘People aren't purely truth-seekers - many beliefs are influenced by ...
Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters
2024-03-28
NEW ORLEANS, La – Newsweek and Plant-A Insights Group have named Ochsner Health one of America's Greatest Workplaces for Job Starters in 2024. In a survey that included more than 75,000 young professionals and more than 540,000 company reviews, Ochsner earned 5 out of 5 stars. As the leading not-for-profit healthcare provider in the Gulf South, Ochsner is committed to championing career development among new professionals.
"We at Ochsner are honored to receive recognition as a place of employment that offers ...
Three-year study of young stars with NASA’s Hubble enters new chapter
2024-03-28
In the largest and one of the most ambitious Hubble Space Telescope programs ever executed, a team of scientists and engineers collected information on almost 500 stars over a three-year period. This effort offers new insights into the stars' formation, evolution, and impact on their surroundings.
This comprehensive survey, called ULLYSES (Ultraviolet Legacy Library of Young Stars as Essential Standards), was completed in December 2023, and provides a rich spectroscopic dataset obtained in ultraviolet light that astronomers will be mining for decades to come. Because ultraviolet light can ...
LAST 30 PRESS RELEASES:
Houston Methodist researchers shed light on increased rates of severe human infections caused by Streptococcus subspecies
Auburn University hosts 62nd Hands-On Workshop on Computational Biophysics, featuring the new VMD 2.0
The Salton Sea — an area rich with lithium — is a hot spot for child respiratory issues
University of Maryland-YouGov poll: Alsobrooks dominates Hogan, amendment to state constitution garners broad support
Exposure to particular sources of air pollution is harmful to children’s learning and memory, a USC study shows
Change of ownership in home health agencies may lead to increased Medicare spending and reduced staffing levels, according to UTHealth Houston research
More resources needed to protect birds in Germany
Mission to International Space Station launches research on brain organoids, heart muscle atrophy, and cold welding
nTIDE November 2024 Jobs Report: Disability employment remains near historic highs over past 18 months
Researchers aim to streamline cancer detection with new method for liquid biopsies
New Huntington’s treatment prevents protein aggregation
Bee gene specifies collective behavior
Jennifer Bickel, M.D., named MD Anderson Vice President and Chief Wellness Officer
Evolutionary paths vastly differ for birds, bats
Political pros no better than public in predicting which messages persuade
Investment in pediatric emergency care could save more than 2,100 young lives annually
The dynamic core of black holes
Improving energy production by boosting singlet fission process
Smoking cessation and incident cardiovascular disease
Cannabis use during early pregnancy following recreational cannabis legalization
Research shows Cleveland Clinic’s therapeutic virtual yoga program can be effective for chronic low back pain
Closing in on Parkinson’s Disease proteins in extracellular vesicles in the blood
Regional and global experts convene in Accra, Ghana to update cancer treatment guidelines for Sub-Saharan Africa
China University of Geosciences (Beijing) unveils clues to an enigmatic geological process
Fueling greener aviation with hydrogen
Education, occupation, and wealth affect the risk of cognitive impairment
Revealing causal links in complex systems
Alzheimer disease as a clinical-biological construct— an international working group recommendation
Press registration now open for the EULAR 2025 Congress in Barcelona
New research identifies ways to protect neurons from the negative effect of high-fat diet on multiple sclerosis progression
[Press-News.org] Cell division quality control ‘stopwatch’ uncoveredMechanism keeps track of the time cells take to split, sounding the alarm on cells that may turn cancerous